Home  |  Contact

UniProtKB/Swiss-Prot P52789: Variant p.Arg353Cys

Hexokinase-2
Gene: HK2
Variant information

Variant position:  353
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:  LB/B
The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change:  From Arginine (R) to Cysteine (C) at position 353 (R353C, p.Arg353Cys).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:  Change from large size and basic (R) to medium size and polar (C)
The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:  -3
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Polymorphism:  Although found in NIDDM patients, genetic variations of HK2 do not contribute to the disease (PubMed:7883122, PubMed:7883123).
Additional information on the polymorphism described.

Other resources:  
Links to websites of interest for the variant.



Sequence information

Variant position:  353
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:  917
The length of the canonical sequence.

Location on the sequence:   RFETKDISDIEGEKDGIRKA  R EVLMRLGLDPTQEDCVATHR
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation: 
The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         RFETKDISDIEGEKDGIRKAREVLMRLGLDPTQEDCVATHR

Mouse                         SFETKDVSDIEDDKDGIQKAYQILVRLGLSPLQEDCVATHR

Rat                           SFETKDVSDIEEDKDGIEKAYQILMRLGLNPLQEDCVATHR

Pig                           HFETKDVSDIEGEKDGIRKAREVLVRLGLDPTQEDCVATHR

Horse                         RFETKDVSEIEGEKDGIQKAREVLVRLGMDPTQEDCVATHR

Drosophila                    --------EIEAAVKG-------------------------

Fission yeast                 --------DFE------------------------------

Sequence annotation in neighborhood:  
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.

TypePositionsDescription
Chain 1 – 917 Hexokinase-2
Domain 16 – 458 Hexokinase 1
Region 208 – 447 Hexokinase large subdomain 1
Helix 348 – 358


Literature citations

Amino acid substitutions in hexokinase II among patients with NIDDM.
Laakso M.; Malkki M.; Deeb S.S.;
Diabetes 44:330-334(1995)
Cited for: VARIANTS VAL-314; CYS-353 AND GLN-775;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.